XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease
NCT01582295
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
4
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Cabozantinib
Sponsor
Massachusetts General Hospital